Recent studies have reported the upregulation of a subgroup of triacylglycerides as markers of different diseases with dysregulated lipogenesis, which means that these markers are not selective. This observation has a deep impact on their use as diagnostic tools in clinical practice (e.g., markers of risk of type 2 diabetes).
Keywords: disease markers; dysregulated lipogenesis; lipidomics; liver X receptors; regulatory element-binding transcription factors; triglycerides.
Copyright © 2019 Elsevier Ltd. All rights reserved.